NanoKon

Systematic evaluation of health effects of nanoscale contrast agents

The NanoKon project intends to systematically study and evaluate the effects of novel nanoparticles, particularly on the gastrointestinal tract. The relevant analyses are carried out using nanoparticles of different surface properties and with certain physico-chemical characteristics determining the interaction of the particles with individual body cells and entire organs.

Publications: 

Press release I (2010) (only available in German)
Press release II (2011) (only available in German)

Tenzer, S., et al., Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano, 2011. 5(9): p. 7155-67.

Duration: 01.10.2010 - 30.09.2013

Project lead:

Hermann Schirra

Partners: